|
Report Title |
Publish
Date |
Price |
Order |
 |
Advances in the Stem Cell Industry: The future impact of innovation, and an evaluation of the commercial landscape |
Oct-09 |
$3835
|
 |
|
 |
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook |
Oct-09 |
$3835
|
|
|
 |
Innovations in
Oncology Diagnostics: Technological advances, growth
opportunities and future market outlook |
Jun-09 |
$3835
|
|
|
 |
Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges |
Jun-09 |
$3835
|
|
|
 |
Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products |
Oct-09 |
$3835
|
|
|
 |
The CMO Market Outlook: Emerging markets, key players and future trends |
Oct-09 |
$3835
|
|
|
 |
The Vaccines Market Outlook To 2014 |
Jun-09 |
$3835
|
|
|
 |
Emerging Clinical Trial Locations |
Jun-09 |
$6710
|
|
|
 |
The Pain Management Market Outlook to 2014 |
Jun-09 |
$3835
Save 15% off the published rate
|
|
|
 |
Key Trends in Drug-Diagnostic Co-Development |
Jul-09 |
$3835
Save 15% off the published rate
|
|
|
 |
Innovations in Protein Kinase Therapies |
Jun-09 |
$3835
Save 15% off the published rate
|
|
|
 |
The Scandinavian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities |
Mar-09 |
$3835
|
|
|
 |
The Top 10 Contract Research Organizations: Positioning, performance and SWOT analyses
|
Mar-09 |
$3835
Save 15% off the published rate |
|
|
 |
The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
|
Apr-09 |
$3835 |
|
|
 |
Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
|
Mar-09 |
$3835
Save 15% off the published rate |
|
|
 |
Technology Transfer Strategies: Maximizing the returns from new technologies
|
Feb-09 |
$3835 |
|
|
 |
Negotiating the Emerging Biosimilars Landscape: Key developments in the regulatory environment
|
Feb-09 |
$3835 |
|
|
 |
The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
|
Jan-09 |
$3835 |
|
|
 |
Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
|
Jan-09 |
$3835 |
|
|
 |
Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
|
Dec-08 |
$3835 |
|
|
 |
The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
|
Dec-08 |
$3835 |
|
|
 |
The Pharmaceutical Market Outlook to 2018: Key threats and opportunities for Big Pharma and its responses to them
|
Nov-08 |
$3835 |
|
|
 |
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery |
Mar-09 |
$3835
|
|
|
 |
The Promotional Landscape
in US and Europe: Benchmarking promotional ROI and optimizing
detailing and journal spend relationships |
Nov-08 |
$3835 |
|
|
 |
Innovative Strategies and Models for R&D Success: The evolving networked pharma company |
Aug-08 |
$3835 |
|
|
 |
Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments |
Aug-08 |
$3835 |
|
|
 |
The Anti-Infectives Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities |
Aug-08 |
$3835 |
|
|
 |
Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments |
Jun-08 |
$3835 |
|
|
 |
The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends |
May-08 |
$3835 |
|
|
 |
Contract Manufacturing Strategies: Market developments, technology transfer and key success factors |
May-08 |
$3835 |
|
|
 |
The
Gastrointestinal Market Outlook to 2012 |
Mar-08 |
$3835 |
|
|
 |
The
Fastest Growing Biotechnology Companies |
Mar-08 |
$3835 |
|
|
 |
Nanotechnology:
Revolutionizing R&D to develop smarter therapeutics |
Jan-08 |
$3835 |
|
|
 |
The
Cancer Market Outlook to 2012 |
Jan-08 |
$3835 |
|
|
 |
Lifestyle
Drugs Market Outlook |
Dec-07 |
$2875 |
|
|
 |
Optimizing
Partnerships with Contract Organizations |
Nov-07 |
$2875 |
|
|
 |
Pharmaceutical
Pricing and Reimbursement |
Nov-07 |
$3835 |
|
|
 |
Drug
Development Opportunities in China |
Sept-07 |
$3835 |
|
|
 |
Immunomodulators:
Therapeutic Needs, Pipelines |
Sept-07 |
$3835 |
|
|
 |
Translational
Medicine in Biopharmaceutical R&D: Enabling R&D
optimization and early detection of potential markets |
Oct-07 |
$2875 |
|
|
 |
Drug Development Opportunities in China: Regulation, key players and initiatives for domestic and international markets |
Sep-07 |
$2875 |
|
|
 |
Biomanufacturing Strategies: Market drivers, build-vs-buy decisions and opportunities in contract relationship management |
Sep-07 |
$2875 |
|
|
 |
Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices |
Sep-07 |
$2875 |
|
|
 |
The Future of Biosimilars: Key opportunities & emerging therapies |
Aug-07 |
$2875 |
|
|
 |
Emerging Pharmaceutical Markets: Growth opportunities, changing healthcare dynamics and regulatory trends |
Apr-07 |
$2875 |
|
|
 |
Drug Repositioning Strategies: Innovative strategies to boost pipeline productivity |
Jun-07 |
$2875 |
|
|
 |
The Women’s Health Market Outlook to 2011 |
Apr-07 |
$2875
$2730
|
|
|
 |
Winning Product Launch Strategies: Maximizing sales from new pharmaceutical products |
Apr-07 |
$2875 |
|
|
 |
Indication Expansion: Opportunities for successful lifecycle management |
Mar-07 |
$2875 |
|
|
 |
eHealth Solutions for Pharma: Strategies for salesforces, marketing, patient compliance and clinical trials |
Mar-07 |
$2875 |
|
|
 |
The Dermatology Market Outlook to 2011 |
Mar-07 |
$2875 |
|
|
 |
The Cardiovascular Market Outlook to 2011 |
Jan-07 |
$2875 |
|
|
 |
Biopartnering Strategies: Maximizing returns from biotechnology deal-making |
Dec-06 |
$2875 |
|
|
 |
Winning R&D Productivity Strategies: Exploiting innovation, licensing and outsourcing opportunities |
Oct-06 |
$2875 |
|
|
 |
Pharmaceutical Strategic Alliances: Maximizing returns from collaborative development and commercialization |
Sep-06 |
$2875 |
|
|
|
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China: Healthcare reform, market dynamics and key players |
Aug-06 |
$2875 |
|
|
|
The Future of
Metabolomics: Building competitive advantage in drug discovery, clinical development and diagnostics |
Aug-06 |
$2875 |
|
|
|
Pharmaceutical Licensing Strategies: Best practices in deal-making, valuations and strategic management |
Jun-06 |
$2875 |
|
|
|
Pharmaceutical Outsourcing Strategies: Market expansion, offshoring and strategic management in the CRO and CMO marketplace |
Apr-06 |
$2587 |
|
|
|
Opportunities in Stem Cell Research and Commercialization: Technology advances, regulatory impact and key players |
Mar-06 |
$2300 |
|
|
